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AbstrAct
Multicellular 3-dimensional (3D) in vitro models of normal human breast tissue 
to study cancer initiation are required. We present a model incorporating three of 
the major functional cell types of breast, detail the phenotype and document our 
breast cancer initiation studies. Myoepithelial cells and fibroblasts were isolated and 
immortalised from breast reduction mammoplasty samples. Tri-cultures containing 
non-tumorigenic luminal epithelial cells HB2, or HB2 overexpressing different HER 
proteins, together with myoepithelial cells and fibroblasts were established in 
collagen I. Phenotype was assessed morphologically and immunohistochemically and 
compared to normal breast tissue. When all three cell types were present, polarised 
epithelial structures with lumens and basement membrane production were observed, 
akin to normal human breast tissue. Overexpression of HER2 or HER2/3 caused a 
significant increase in size, while HER2 overexpression resulted in development of 
a DCIS-like phenotype. In summary, we have developed a 3D tri-cellular model of 
normal human breast, amenable to comparative analysis after genetic manipulation 
and with potential to dissect the mechanisms behind the early stages of breast cancer 
initiation.
IntroductIon
Researchers are beginning to appreciate the need 
for more complex multicellular three-dimensional 
(3D) laboratory models in order to study the processes 
associated with disease progression. In recent years there 
has been a shift towards developing 3D in vitro models 
that better represent breast tissues. These typically involve 
culturing breast epithelial cells alone or with fibroblasts 
[1-3] in 3D in the presence of extracellular matrix (ECM) 
such as MatrigelTM or collagen I. Mammary luminal 
epithelial cells respond to ECM by forming acini-like 
structures [4]. By culturing cells with specific ECM 
constituents, cell-cell and cell-ECM interactions can be 
represented in the laboratory [5]. This has led to a better 
understanding of how different breast cell types interact 
with each other and the surrounding ECM as well as 
identification of key intercellular signalling proteins 
involved in maintaining luminal cell polarity such as 
integrins [6] and cadherins [7]. 
Current 3D in vitro models of normal human breast 
are limited. Compared to the wealth of breast cancer cell 
lines available to represent the molecular subtypes of 
breast cancer [8], normal breast epithelial cell lines are 
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scarce. MCF10A is the most commonly used cell line to 
represent normal breast. When cultured in MatrigelTM, 
polarised acini-like structures with hollow lumens 
develop which produce basement membrane proteins 
[9, 10]. These models often incorporate fibroblasts [1-
3]. However, MCF10A cells have a propensity to adopt 
a basal phenotype [11, 12] and are sensitive to changes 
in culture conditions [13] making them challenging to 
work with. Furthermore there are limitations to using 
MatrigelTM; although used widely, the levels of growth 
factors and basement membrane components are 
heterogeneous [14] and the substance itself is prepared 
from Engelbreth-Holm-Swarm mouse sarcoma cells. The 
main constituent of breast stroma is collagen I [15], a 
regulator of morphology and phenotype of breast epithelial 
cells [1, 16, 17]. Moreover, variation in the amount of 
collagen and subsequent mammographic density may be 
linked to the onset of breast cancer [18, 19]. Thus the case 
for incorporating collagen I in the development of 3D in 
vitro models of breast tissue is strong. 
In addition to the role fibroblasts play on 
regulating luminal epithelial behaviour [20-22], breast 
myoepithelial cells are important in maintaining luminal 
epithelial polarisation and architecture [23, 24]. These 
are considered tumour suppressive [25, 26], expressing 
a number of tumour suppressor proteins e.g. maspin and 
ERβ, structural ECM proteins e.g. fibronectin, proteinase 
inhibitors e.g. tissue inhibitor of metalloproteinase-1 
(TIMP1) and angiogenic inhibitors e.g. thrombospondin-1 
[25, 27, 28]. However, studies incorporating these cells 
into 3D models are limited. 
This study aimed to create in vitro a 3D tri-culture 
system of normal human breast that incorporates an 
alternative normal luminal epithelial cell line HB2 
[29, 30], together with myoepithelial and fibroblast 
cells in a physiologically relevant matrix, collagen I. 
We demonstrated that the model is representative of 
normal human breast by comparing the morphology 
and immunoprofile to ‘gold standard’ normal human 
breast tissue sections, and determined that the model 
was amenable to cancer initiation studies through HER 
overexpression in luminal epithelial cells.
results
3d in vitro tri-culture model recapitulates the 
morphology and phenotype of normal human 
breast tissue 
HB2 cells were cultured alone, with Myo1089 
cells or with Myo1089 and fibroblasts in collagen I gels 
and phenotype assessed by H&E after 21 days. When 
cultured alone, HB2 cells formed tight spherical units 
of varying size with occasional scattered cells (Figure 
1a, 1b). A similar phenotype was observed when HB2 
were co-cultured with Myo1089 cells (Figure 1c, 1d). 
Tri-culture of HB2, Myo1089 and fibroblasts, resulted 
in the arrangement of Myo1089 myoepithelial cells 
around the outer edges of spherical lumen containing 
HB2 epithelial cells with fibroblasts loosely distributed 
throughout the collagen gel (Figure 1e) akin to normal 
breast acini (Figure 1f). This phenotype was only observed 
when all 3 cell types were present. Spatial localisation of 
myoepithelial cells and fibroblasts were confirmed by 
immunohistochemistry (Figure 1g, 1h), respectively.
We then conducted immunohistochemical 
characterisation of 3D in vitro tri-cultures and compared 
this to normal human breast tissue. As shown in Figure 2, 
tri-culture phenotype (a-d, i-l) was strikingly similar to that 
of normal breast tissue (e-h, m-p). Controls (no primary 
antibody) are shown in Figure 2a and 2i. E-cadherin 
(E-cad) was expressed at cell-cell junctions (Figure 2b, 
2f) with EMA at apical membranes (Figure 2c, 2g). Some 
cell proliferation was identified by Ki67 staining (Figure 
2d, 2h), with apoptosis detected within central lumens 
by M30 staining (Figure 2i, 2m). α-SMA was specific 
to myoepithelial cells (Figure 2j, 2n) while basement 
membrane production was detected around outer edges of 
breast ducts by collagen IV expression (Figure 2k, 2o). 
Vimentin expression was detected in both myoepithelial 
cells and fibroblasts (Figure 2l, 2p). Comparison of these 
immunohistochemical features to normal breast tissue 
sections demonstrated strikingly strong similarities. 
overexpression of Her proteins affect the 
morphology and phenotype of the tri-culture 
model
To test whether the tri-culture model was suitable 
for cancer initiation studies, HER2 and HER3 proteins 
were overexpressed in HB2 cells. Protein presence was 
confirmed by western blot analysis (Figure 3a). Compared 
to controls (Figure 3b) upon HER2 overexpression, HB2 
cells formed larger, elongated units with distorted lumens 
and the appearance of protrusions from outer edges 
(Figure 3c). HER3 overexpressing cells also formed larger 
units containing distorted lumens but retained a spherical 
shape (Figure 3d). HB2 cells overexpressing both HER2 
and HER3 formed a combination of smaller rounded 
units and larger elongated units that were larger than 
HB2 controls and also featured distorted lumens (Figure 
3e). Quantitative analysis supported these observations. 
HB2 co-units significantly increased in size following 
HER2, or HER2/3 overexpression (Figure 3f, p = <0.05). 
Overexpression of HER3 induced a significant decrease 
(Figure 3g, p = 0.0442) in co-unit formation, while 
overexpression of HER2, HER3 and HER2/3 caused a 
decrease in lumen formation compared to HB2 controls 
(Figure 3h, p = <0.05). To examine if all 3 cell types 
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Figure 1: comparison of morphology of 3d tri-culture model with normal human breast tissue. When cultured alone 
(a, b), HB2 cells formed tight spherical units of varying size with occasional scattered cells. A similar phenotype was observed when 
HB2 were co-cultured with Myo1089 cells (c, d). In tri-cultures containing HB2, Myo1089 and fibroblasts, ductal structures with hollow 
lumens (dotted arrow) were observed surrounded by a border of clear myoepithelial cells (arrow; e) akin to normal human breast acini (f). 
Immunohistochemical characterisation using tGFP and dsRed antibodies confirmed the distribution of myoepithelial cells at the outer edges 
of HB2 structures with hollow lumens (dotted arrow) (arrows; g) and fibroblasts loosely distributed throughout collagen gels (arrows; h), 
respectively. Scale bars = 100 µm
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were necessary to mediate these phenotypic changes, 
HER overexpressing HB2 cells were co-cultured with 
either myoepithelial cells or fibroblasts. Co-culture with 
myoepithelial cells had an organisational effect inducing 
the formation of rounded cohesive units while co-culture 
with fibroblasts had the opposite effects, resulting in larger 
co-units with a discohesive and disorganised appearance 
(Suppl. Figure 3).
Her2 overexpressing Hb2 3d tri-cultures 
resemble human dcIs phenotype 
H&E stained sections of HER2 overexpressing 
and HB2 control 3D tri-cultures were compared with a 
cross section of a human breast tissue that contained 
areas of both DCIS and normal adjacent acini (Figure 
4a). As previously, HB2 control units were small, 
rounded, contained lumens (Figure 4b) and were similar 
phenotypically to normal breast acini (Figure 4a). In 
the breast tissue section, areas of DCIS featured large 
elongated ducts and contained distorted lumens with 
necrotic tissue (Figure 4a). These also contained enlarged 
and discohesive cells. HER2 overexpressing HB2 units 
were similarly elongated in shape, containing discohesive 
cells with distorted luminal spaces thought to be a 
product of necrosis (Figure 4c). Immunohistochemical 
characterisation showed no change in Ki67 expression 
between HB2 control units or those containing HER2-
overexpressing cells, however a reduction in M30 and 
E-cadherin was observed (Suppl. Figure 4), suggesting 
these morphological changes are a result of apoptosis 
and loss of cell adhesion. This not only confirmed that 
the normal 3D tri-culture model was robust and retained 
features of normal breast acini, but also that morphological 
and phenotypical features of DCIS could be recapitulated 
through overexpression of HER2 in the 3D tri-culture 
model. 
Figure 2: Comparison of immunohistochemical profiles of 3D tri-cultures with those of normal breast tissue. The 
phenotype of 3D in vitro tri-cultures (a-d; i-l) was assessed by immunohistochemistry and compared to cross sections of breast reduction 
mammoplasty tissue (e-h; m-p). Negative controls (a, e). E-cadherin was expressed by HB2 epithelial cells at cell-cell junctions (b, arrow) 
similar to luminal epithelium of breast acini (f, arrow). EMA expression was concentrated at the HB2 cell-lumen interface in co-units (c) 
and was specific to apical membranes of luminal epithelium of breast acini (g, arrow).The majority of cells within HB2 co-units expressed 
Ki67 (d) with scattered positivity within breast acini (h). M30 staining demonstrated apoptosis within lumens of HB2 co-units (i, arrow) and 
also in breast acini (m, arrow). α-SMA was restricted to myoepithelial cells on the periphery of HB2 co-units (j, arrow) while a continuous 
layer of α-SMA positive myoepithelial cells surround luminal epithelium of breast acini (n, arrow).Collagen IV was concentrated around 
outside edges of HB2 co-units (k, arrow) and similarly is demonstrated encapsulating breast acini (o, arrow). Vimentin was expressed in 
both Myo1089 cells (M) and fibroblasts (F) in the tri-culture model (l) analogous to Vimentin positivity in myoepithelial cells (M) and 
fibroblasts (F) in normal breast tissue (p). Original magnification for tri-culture model = 20x; for normal tissue = 40x. 
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Figure 3: overexpression of Her proteins in Hb2 cells affects 3d architecture. Stable overexpression of HER2 and HER3 
in HB2 cells was shown by western blot (a). WT cells in 3D tri-culture (b) formed rounded units (RU) with lumens (L). When HER2 
was overexpressed (c), formation of much larger elongated units (EU) with distorted lumens (DL) and protrusions (PRO) from edges was 
observed. HER3 overexpression (d) resulted in rounded units with distorted lumens (DL) while overexpression of HER2 and HER3 cells 
(e) resulted in a combination of rounded units (RU) and elongated units (EU) with distorted lumens (DL). Quantitative analysis confirmed 
HER2 and HER2/3 overexpression induced significantly larger HB2 unit formation (f). Only HER3 overexpression alone significantly 
altered the number of HB2 units formed (g) while HER2, HER3 and HER2/3 overexpression significantly reduced lumen formation (h). 
Bars denote mean from three gel replicates and error bars standard error of the mean (SEM). * = p < 0.05
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dIscussIon
With scientists now recognising the importance of 
the microenvironment in cancer initiation and progression, 
there is an increased need for robust 3D in vitro models 
which incorporate components of the microenvironment. 
Here, we present, a 3D in vitro model of normal human 
breast that incorporates not only breast luminal epithelium 
with fibroblasts, but also myoepithelial cells all embedded 
in the physiologically relevant matrix collagen I. 
This model reflects the morphology and phenotype of 
normal breast providing a novel tool to investigate the 
mechanisms behind the early events of cancer initiation 
and the formation of pre-malignant lesions.
Following optimisation of culture conditions 
including culture medium, cell numbers and duration 
of culture (data not shown), we demonstrated that co-
culturing the three major cell types comprising the 
mammary duct in collagen I resulted in the arrangement of 
a border of myoepithelial cells surrounding HB2 epithelial 
cells which formed ductal structures with hollow lumens, 
with fibroblasts loosely distributed throughout the collagen 
gel. This morphology was remarkably similar to ‘gold 
standard’ normal human breast acini. It was necessary 
to use HB2 cells instead of the more commonly used 
MCF10A cells as we found that, as others have reported 
[11, 12], the latter exhibited plasticity, with evidence of at 
least 2 different sub-populations particularly when these 
were incorporated into more complex multicellular 3D 
collagen I models (Nash et al., manuscript in preparation).
This was confirmed further by immunohistochemical 
analysis of a panel of breast epithelial and mesenchymal 
markers and expression profiles compared to normal 
breast tissue. Near-identical expression patterns provided 
confidence that our 3D in vitro tri-culture model was a 
robust model of normal human breast tissue. Deposition 
of basement membrane protein collagen IV around the 
outer edges of co-units was observed, supporting previous 
reports that inclusion of myoepithelial cells with luminal 
epithelial cells in 3D collagen I matrix can abrogate 
Figure 4: comparison of Her2 overexpressing tri-cultures to human breast tissue containing dcIs. A cross section of 
human breast tissue (a) shows normal acini which are small and rounded with cleared central lumens (L, inset). Areas of DCIS consist of 
elongated discohesive cells (DC) with distorted lumens containing necrotic cells (DL). Co-units of the tri-culture model are also small and 
rounded with central lumens (L), strongly resembling normal breast acini. Overexpression of HER2 in luminal epithelium (c) resulted in 
an elongated, branched shape, the appearance of distorted lumen with possible necrosis (DL) and also discohesive cells (DC), reminiscent 
of a DCIS-like phenotype. Original magnification x20 (tri-culture model); 40x (breast tissue). 
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the need for basement membrane preparations such as 
MatrigelTM [24] due to their ability to produce proteins 
required for basement membrane formation [25]. All 
co-units displayed E-cadherin expression between HB2 
cell junctions with epithelial membrane antigen situated 
at the apical-luminal interface of HB2 cells indicating 
the polarisation of HB2 cells. The presence of lumens 
cleared via apoptosis as detected by M30 expression. 
In addition, we proved that each cell type retained a 
phenotype representative of their corresponding cell type 
in normal breast tissue with vimentin expression detected 
in Myo1089 and fibroblasts and α-smooth muscle actin 
found in Myo1089 cells only. Continued correlation to 
normal human breast tissue supports the validity of the 
tri-cultures as models of normal breast acini.
We then sought to determine if the model could 
be used as a tool to study cancer initiation processes. 
Focussing on the luminal epithelium, we aimed to disrupt 
the normal architecture to produce a morphology and 
phenotype akin to early pre-malignant breast lesions, 
through overexpression of HER proteins. HER2 gene 
amplification and protein overexpression is observed in 
around 16% of breast cancers [31] and is associated with a 
poor prognosis and survival in breast cancer patients due to 
its relationship with more aggressive tumours [32]. HER2 
overexpression also occurs in up to 50% of DCIS [33] 
suggesting a role in cancer initiation with murine studies 
demonstrating HER2 overexpression alone is sufficient 
to induce transformation of mammary epithelium in a 
single step [34, 35]. This demonstrates the potency of 
HER2 as an oncogene. The HER2-HER3 heterodimer is 
the most potent and mitogenic heterodimer of the HER 
family. The potential of the HER2-HER3 heterodimer 
to activate PI3K [36] and the MAPK pathway [37, 38] 
makes HER2 a key regulator of a variety of cell responses 
such as proliferation, apoptosis and differentiation. Our 
study demonstrated that overexpression of HER2 alone 
had the most dramatic effect on the architecture of co-
units. These were significantly larger, more elongated 
and less cohesive, and featured protrusions similar to 
DCIS. Furthermore, lumen formation was significantly 
reduced within these co-units. Immunohistochemical 
characterisation suggested that these features may be 
attributed to apoptosis and a reduction in cell adhesion. 
Previous reports have proposed that HER2 overexpression 
in MCF10A cells in 3D Matrigel™ can result in evasion of 
apoptosis, lumen filling, disengagement of inner cell layers 
from the basement membrane, an increase in epithelial-
mesenchymal transition and cell migration, and that these 
can be attributed to the cooperation of EGF signalling with 
the TGF-β signalling pathway and alteration of integrin 
signalling [39-41]. 
Despite reports implicating the HER2-HER3 
heterodimer as the most potent and mitogenic dimer pair 
[36-38], in our model, HER3 or HER2/3 overexpression 
had a less pronounced effect on epithelial architecture, 
suggesting that the HER2-HER3 heterodimer was not the 
most potent inducer of aberrant epithelial architecture. 
Previous reports have demonstrated that the HER2-EGFR 
heterodimer is also strongly mitogenic and can drive cell 
migration [42, 43]. 
The effect of HER overexpression on luminal 
epithelial architecture has not been studied previously in 
the presence of both myoepithelial cells and fibroblasts. 
Here, we illustrated that myoepithelial cells in co-culture 
with HB2 cells appeared to diminish the disruptive effects 
of HER overexpression, akin to their recognised tumour 
suppressive role. On the other hand, co-culture with 
fibroblasts appeared to promote the opposite effect. 
In summary we have successfully produced a robust 
heterotypic 3D in vitro model of normal human breast 
tissue that incorporated the three major cell types found in 
the breast in a physiologically relevant matrix of collagen 
I. We demonstrated individual cell populations were 
traceable, and formed co-units which shared morphology 
and phenotype with breast acini of the normal human 
mammary gland. Phenotypically, HER2 overexpressing 
tri-cultures had a strikingly similar phenotype to DCIS. 
Features such as elongated shape, distorted lumens, 
the presence of discohesive cells and necrosis were all 
recapitulated upon overexpression of HER2 in the model. 
The ability to produce structures that reflect early pre-
malignant lesions such as DCIS in a physiologically 
relevant context validated the suitability of our model for 
cancer initiation studies. The model is robust, amenable to 
genetic manipulation and can be analysed and quantified 
by standard laboratory techniques. Our in vitro model 
could be used to dissect the mechanisms behind the early 
stages of breast cancer initiation. 
MAterIAls And MetHods
tissue
Reduction mammoplasty samples were collected 
with informed consent via the Leeds Breast Cancer 
Campaign Tissue Bank following ethical approval (REC: 
09/H1306/108, 10/H0308/48). 
cell culture
The non-tumorigenic breast epithelial cell line, 
HB2, was used [44]. The myoepithelial cell line Myo1089 
was derived from breast reduction mammoplasty tissue 
and transduced with SV40 large T antigen [2] (gift from 
Professor Mike O’Hare, Ludwig Institute, London, 
UK). HB2 cells overexpressing HER2 and HER3 were 
generated through transfection of pSV2-HER2 [45] or 
retroviral transduction of pLXSN-ErbB3 [46], followed 
by single-stain or double-stain fluorescence activated 
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cell sorting (FACS) for HER2 and HER3 or HER2/3 
overexpressing cells, respectively to isolate >95% pure 
cell populations. Fibroblasts were isolated from breast 
reduction mammoplasty tissue [47] and retrovirally 
transduced with pBABE-neo-hTERT [48] to increase 
longevity. Quarterly mycoplasma tests were consistently 
negative. With the exception of fibroblasts isolated in-
house, all cells were Short Tandem Repeat profiled 
annually by the Leeds Institutes of Molecular Medicine 
Genomics facility confirming no cross-contamination (last 
tested April 2014). 
Western blotting
This was performed as previously [47] using 
NuPAGE® Novex® 4-12% Bis-Tris Gels (Invitrogen, 
Carlsbad, CA, USA) and proteins transferred to 
polyvinylidene difluoride membrane (Amersham 
Biosciences, Buckinghamshire, UK). Membranes were 
incubated (4oC overnight) with HER2 IgG (Rabbit 
Polyclonal, Cell Signalling Technology, dilution 1:1000), 
HER3 IgG (Mouse monoclonal, Clone 2F12, Millipore, 
dilution 1:1000) or β-actin IgG (Clone AC-15, Sigma, 
dilution 1:10000) and HRP conjugated secondary 
antibodies (Santa Cruz Biotechnology, Santa Cruz, 
USA; dilution 1:10000; 1 hr) before visualisation with 
SuperSignal West Pico Chemiluminescent Substrate 
(Thermo Scientific, Loughborough, UK).
3d collagen gel culture
Myo1089 cells and fibroblasts were fluorescently 
labelled with pGIPZ-tGFP and pFURW-dsRed lentiviral 
vectors respectively and generated using a 2nd generation 
lentiviral packaging system [49] to enable tracking in 
culture (Suppl. Figure 1) using immunohistochemistry. Rat 
Tail Collagen I (BD Biosciences, USA) was diluted with 
Dulbecco’s Phospho Buffered Saline (DPBS, Invitrogen, 
Carlsbad, CA, USA; 2mg/mL [2] and mixed with eight 
parts of collagen solution (2mg/mL) to one part 10x Hanks 
Buffered Salt Solution (HBSS, Sigma, Poole, UK)). The 
gel was neutralised by drop-wise addition of NaOH 
until a pink-orange colour was achieved. 3D gel culture 
medium was prepared (50% complete HAMF12 Nutrient 
Mixture (Sigma, Poole, UK); 50% complete Dulbecco’s 
modified Eagle’s medium (DMEM, Invitrogen, Carlsbad, 
CA, USA)). Myo1089, HB2 and fibroblast cells were 
mixed (6:2:1, respectively) in one volume of the above 
media to achieve a cell density of 4x105 cells /mL gel. 
This was determined empirically and the ratio which best 
represented normal breast tissue phenotype (judged by 
AMH, a specialist breast histopathologist), was selected. 
200µl of the gel-cell mixture was added to 12-well plate 
Transwell® cell culture inserts with PET membranes and 
8.0µm pore size (BD Falcon®, USA) and placed within 
wells of a culture plate (Costar, Corning Inc, Corning, 
USA). Gels were allowed to solidify (20 mins 37oC in 5% 
CO2) before adding 500µl of media to the top of each gel 
and 1mL to the bottom of each well in the cell culture 
plate. Gels were cultured for 21 days with 50% of the 
media being replaced every three days during this time. 
Gels were fixed in 10% formalin (Sigma, Poole, UK) 
for 5 hours, processed (Leica ASP 200 tissue processor), 
paraffin embedded and 5µm sections taken using a Leica 
RM2235 microtome (both Leica Microsystems, Milton 
Keynes, UK) and mounted onto Superfrost Plus slides 
(BDH, Poole, UK). All slides were H&E stained allowing 
visualisation.
Immunohistochemistry 
This was performed on 5µm sections from reduction 
mammoplasty tissue and 3D gels. Primary antibodies 
included: vimentin (Clone Vim 3B4, 1:200), epithelial 
membrane antigen (EMA; Clone E29, 1:5000), α-smooth 
muscle actin (αSMA; Clone 1A4, 1:200), E-cadherin 
(Clone NCH-38, 1:100), Ki67 (Clone MIB1, 1:1000) [all 
Dako, Glostrup, Denmark], collagen IV (Clone COL-
94, 1:100, Sigma, Poole, UK], M30 (mouse anti-human 
monoclonal, Clone M30, 1:50, Roche Diagnostics, West 
Sussex, UK), turboGFP (rabbit polyclonal, 1:500, Pierce, 
Northumberland, UK) and dsRed (rabbit polyclonal, 
1:200, Clontech Laboratories Inc, CA, USA). Primary 
antibody omission served as negative controls in each 
run. Antibodies were incubated overnight at 4oC with 
the exception of turboGFP and dsRed (2 hours, room 
temperature). Heat-induced antigen retrieval was used 
with the exception of those incubated with collagen IV 
which required proteolytic antigen retrieval. Here, sections 
were incubated at 37oC for 20 mins in 20µg/mL Proteinase 
K (Fungal, Invitrogen, Carlsbad, CA, USA) in Phosphate 
Buffered Saline (PBS) prior to blocking. An extra blocking 
step was used prior to antibody incubation; sections were 
rinsed twice with 2% Bovine Serum Albumin (BSA, 
Sigma, Poole, UK) in PBS before adding 100µl 20% goat 
serum (Dako, Glostrup, Denmark) in PBS (incubation at 
room temperature for 20 mins). 
Image acquisition 
Slides were scanned (Aperio CS and AT scanners; 
Aperio Technologies Inc, Vista, CA, USA) using x20 and 
x40 objectives producing images with a final resolution 
of 0.23 and 0.43µm per pixel respectively. Digital images 
were acquired using Aperio Imagescope software version 
11.
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Quantification of 3D in vitro tri-culture model
Annotation tools were used to outline the perimeters 
of the whole gel section from digital images at 20x 
magnification, any holes within the gel section and around 
HB2 units were excluded manually using a computer 
equipped with a Wacom Cintiq touchscreen monitor. 
A viable HB2 unit was defined as a cohesive cluster of 
four or more cells with discernible nuclei. To ensure that 
units quantified were comprised of HB2 cells, IHC was 
performed alongside H&E of the gels to confirm that the 
structures being annotated did not contain turboGFP or 
dsRed positive cells. HB2 units on the periphery of the gel 
section or holes were excluded as they did not represent 
the majority of HB2 structures within the gels (Suppl. 
Figure 2). Aperio Imagescope software calculated the 
number of annotations drawn and area of each annotation 
in µm2. Lumen formation was defined as a space within 
HB2 units that was enclosed by a continuous chain of cells 
and was counted manually. Any HB2 units that contained 
luminal spaces with breaches in the surrounding cells were 
excluded (Suppl. Figure 2). The area of the gel section 
was calculated by subtracting the area of holes in the gel 
from the total area of the gel section. Due to the inherent 
variation between the size of gel sections and therefore 
the number of units within each gel, the area of HB2 units 
were normalised by expressing the area of the unit per 
µm2 of gel. This was calculated by taking the area of each 
HB2 unit and dividing by the area of the gel section. For 
each experiment, one section from three replicate gels for 
each variable was quantified. Raw data was inputted into 
GraphPad Prism 6 software where the mean and SEM was 
calculated along with statistical analysis. For comparison 
of the area, number and lumen formation, unpaired t-test 
analysis was performed where p < 0.05 was considered 
significant.
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